Testing labs in Dover

Medical Engineering Technologies (MET) is an ISO/IEC 17025-accredited contract testing laboratory based in Dover, Kent, United Kingdom, operating as part of the Cormica group of pharmaceutical and medical device testing laboratories. Established in 1997, MET specialises in end-to-end analytical, physical, functional and packaging testing for medical device, combination product and pharmaceutical manufacturers. The laboratory positions itself as the destination for medical and combination device batch release and design validation testing, helping manufacturers bring safe, effective and compliant products to market without unnecessary delay. As a Cormica laboratory, MET sits within a wider network of GMP-, GLP- and ISO 17025-accredited facilities spanning the UK, Europe and the United States — including Portsmouth/Gosport (Wickham Micro) and Bradford in the UK, Reichenau in Germany (Zwisler Laboratory), and Allentown (Pennsylvania), Palm Harbor (Florida) and Cherry Hill (New Jersey) in the US, with a London head office. This means a quote sent to MET draws on more than six decades of combined group heritage and complementary capabilities across analytical chemistry, microbiology and physical testing, with global regulatory reach. MET itself has delivered testing to medical device and pharmaceutical companies in over 20 countries across Africa, Asia, Australasia, Europe and the USA. MET's core strength is physical and functional device testing combined with analytical chemistry. The laboratory performs design verification and validation of devices such as catheters, wound dressings, drug-delivery devices and implants, including mechanical performance testing, dose-delivery accuracy assessment and functional evaluation. These studies support both design verification and ongoing batch release, with protocols developed from an initial product review and risk analysis tailored to each project. A particular area of world-leading expertise is extractables and leachables (E&L) studies and chemical characterisation. MET supports the chemical characterisation of medical devices and combination products in line with ISO 10993-18, evaluating the migration of substances from device materials and packaging to underpin biocompatibility and toxicological risk assessments. This analytical chemistry capability extends to combination products such as prefilled syringes, autoinjectors and inhalation/drug-delivery systems, where the interaction between drug formulation and device materials must be characterised in detail. The laboratory also provides comprehensive packaging and sterile barrier system testing. Services include sterile barrier validation, seal strength and seal integrity testing, package integrity evaluation, and transit/distribution simulation, alongside accelerated and real-time ageing studies to establish shelf life. MET has demonstrated specialised capability in areas where few other laboratories can help, such as odour-control testing and gas-permeability evaluation of packaging materials, reflecting a flexible, problem-solving approach to unusual testing requirements. Stability and longitudinal study work forms another pillar of MET's offering. The lab runs stability studies for performance and safety assessment of delivery devices, implants and pharmaceutical products, supporting formulation stability, performance over time and post-market surveillance needs. Reporting is offered in flexible formats suited to short urgent projects through to extended multi-timepoint programmes, with the group's microbiology laboratories adding sterility testing, sterilisation validation, bioburden and environmental monitoring to complete the medical device lifecycle picture. Quality and regulatory compliance are central to MET's credibility as a testing partner. The Dover laboratory is accredited to ISO/IEC 17025 for validation testing and works to the principles of GMP for batch release testing, with GLP capability available across the Cormica group. The group operates to recognised regulatory frameworks referenced by UKAS, FDA, MHRA and EU MDR, giving manufacturers confidence that data generated will stand up to regulatory scrutiny in major markets. Clients consistently highlight MET and Cormica's technical knowledge, responsiveness and willingness to take ownership of difficult, time-critical projects — including sterility testing, specialised odour and gas-permeability studies, and urgent extensive studies on tight schedules. For medical device, combination product and pharmaceutical manufacturers seeking a single, accredited partner for physical, packaging, stability and analytical chemistry testing — particularly extractables and leachables and combination device characterisation — MET offers deep specialist expertise backed by a global accredited laboratory network.

ISO/IEC 17025 accredited by UKAS (No. 0768) testing laboratory (accreditation status: active). Accredited test areas include: Calibration Electrical. Located at CT17 9EN, Dover, United Kingdom.